Sign in
4

Changes in Ownership

Amneal Pharmaceuticals, Inc. Filed Acc 0001209191-22-044013

Options or other derivatives

  • Director acquired 54,949 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Autor Deborah M. Director 2022-07-29 Grant or award · Restricted Stock Units +54,949 54,949 D
Loading xslF345X03/doc4.xml…